Anti-Angiogenic Effects of Ocimum basilicum Ethanolic Extract: In Vitro and Ex Vivo Evidence of Endothelial Inhibition

Autores/as

  • Ibrahim Aldeeb Faculty of pharmacy, Zarqa University, Zarqa, 13132, Jordan
  • Qasem Abdallah Department of Pharmacology and Biomedical Sciences, Faculty of Pharmacy and Medical Sciences, University of Petra, P.O. Box 961343, Amman 11196, Jordan
  • Amin Malik Shah Abdul Majid Eman Biodiscoveries, Kedah Halal Park, Kawasan Perindustrian Sungai Petani, 08000 Sungai Petani, Kedah
  • Melissa Kilus Department of Toxicology, Advanced Medical and Dental Institute (AMDI), Sains@BERTAM, Universiti Sains Malaysia, Kepala Batas, 13200, Pulau Pinang, Malaysia
  • Nozlena Abdul Samad Department of Toxicology, Advanced Medical and Dental Institute (AMDI), Sains@BERTAM, Universiti Sains Malaysia, Kepala Batas, 13200, Pulau Pinang, Malaysia

DOI:

https://doi.org/10.12873/

Palabras clave:

angiogenesis, anti-inflammatory, cytotoxicity, Ocimum basilicum

Resumen

Background: Angiogenesis and inflammation are two linked processes that exacerbate solid malignancies such as colorectal cancer. Bearing this in mind, it was important to study the anti-angiogenic properties of a well-known anti-inflammatory herb, Ocimum basilicum Lamiaceae (OB). Although many studies have explored the OB cytotoxic properties against a panel of cell lines, to the best of our knowledge, this is the first study that aims to investigate the in vitro and ex vivo anti-angiogenic properties of OB. Methods: Ethanolic extract of Ocimum basilicum leaves (OBL70) was prepared in 70% ethanol. Its half-maximal (IC50) inhibitory concentration on HT29 and EA.hy926 cells were evaluated using viability assay. Its antiangiogenic activities were investigated through ex vivo rat aorta ring assay, migration assay, invasion assay, and tube formation assay. Results and Conclusion: OBL70 demonstrated selective cytotoxicity against EA.hy926 endothelial cells and HT29 cells with IC50 value of 79.78± 2.35 and >100 µg/ml respectively. At 100 µg/ml, 7 days exposure to OBL70 significantly inhibited rat aortic formation of new blood vessels by 77.46 ± 9.3% while the percentage of EA.hy926 survival after 96h exposure was reduced to 71.6± 4.1 %. In addition, OBL70 inhibited EA.hy926 migration by 59.1 % ± 1.17 and 49.5 % ± 3.79 at 12 and 24 h. OBL70 also decreased the number of endothelial cell invasion through the Matrigel by 31.51 ± 2.37%. Notably, at both 200 and 100 µg/ml, OBL70 was able to stop tube formation totally. These significant findings suggest promising potential for translation into anti-angiogenic therapeutic agent.

Biografía del autor/a

  • Ibrahim Aldeeb, Faculty of pharmacy, Zarqa University, Zarqa, 13132, Jordan

    Faculty of pharmacy, Zarqa University, Zarqa, 13132, Jordan

  • Qasem Abdallah, Department of Pharmacology and Biomedical Sciences, Faculty of Pharmacy and Medical Sciences, University of Petra, P.O. Box 961343, Amman 11196, Jordan

    Department of Pharmacology and Biomedical Sciences, Faculty of Pharmacy and Medical Sciences, University of Petra, P.O. Box 961343, Amman 11196, Jordan

  • Amin Malik Shah Abdul Majid, Eman Biodiscoveries, Kedah Halal Park, Kawasan Perindustrian Sungai Petani, 08000 Sungai Petani, Kedah

    Eman Biodiscoveries, Kedah Halal Park, Kawasan Perindustrian Sungai Petani, 08000 Sungai Petani, Kedah

  • Melissa Kilus, Department of Toxicology, Advanced Medical and Dental Institute (AMDI), Sains@BERTAM, Universiti Sains Malaysia, Kepala Batas, 13200, Pulau Pinang, Malaysia

    Department of Toxicology, Advanced Medical and Dental Institute (AMDI), Sains@BERTAM, Universiti Sains Malaysia, Kepala Batas, 13200, Pulau Pinang, Malaysia

Referencias

Liu ZL, Chen HH, Zheng LL, Sun LP, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther. 2023 May 11;8(1):198.

Afonina IS, Zhong Z, Karin M, Beyaert R. Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome. Nat Immunol. 2017;18(8):861.

Melincovici CS, Bosca AB, Susman S, Marginean M, Mihu C, Istrate M, et al. Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455–67.

Lapeyre-Prost A, Terme M, Pernot S, Pointet AL, Voron T, Tartour E, et al. Immunomodulatory activity of VEGF in cancer. In: International review of cell and molecular biology. Elsevier; 2017. p. 295–342.

Ohta T, Kato T, Kawakami H, Miyake Y, Goto M, Iwamoto S, et al. Phase II study of 5-fluorouracil–leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802). Int J Clin Oncol. 2020 Jul 26;25(7):1291–8.

Itatani Y, Kawada K, Yamamoto T, Sakai Y. Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF Pathway. Int J Mol Sci. 2018 Apr 18;19(4).

Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, et al. Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol. 2015 Dec;35 Suppl(Suppl):S224–43.

Gamallo JP, Espere G, May D, N Blanes D, G Abuda F, Joy Labarda H, et al. Evaluation of antiangiogenic property of Ocimum basilica ethanolic leaf extract by using duck embryo chorioallantoic membrane (cam) assay and its morphometric analysis. Vol. 22, International Journal of Herbal Medicine. 2016.

Nicosia RF, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest. 1990;63(1):115–22.

Zihlif M, Afifi F, Abu-Dahab R, Majid AMSA, Somrain H, Saleh MM, et al. The antiangiogenic activities of ethanolic crude extracts of four Salvia species. BMC Complement Altern Med. 2013;13(1):358.

Nambiar DK, Kujur PK, Singh RP. Angiogenesis assays. In: Cancer Chemoprevention. Springer; 2016. p. 107–15.

Tabana YM, Hassan LEA, Ahamed MBK, Dahham SS, Iqbal MA, Saeed MAA, et al. Scopoletin, an active principle of tree tobacco (Nicotiana glauca) inhibits human tumor vascularization in xenograft models and modulates ERK1, VEGF-A, and FGF-2 in computer model. Microvasc Res. 2016;107:17–33.

Orhan F, Barış Ö, Yanmış D, Bal T, Güvenalp Z, Güllüce M. Isolation of some luteolin derivatives from Mentha longifolia (L.) Hudson subsp. longifolia and determination of their genotoxic potencies. Food Chem. 2012;135(2):764–9.

Baker M, Robinson SD, Lechertier T, Barber PR, Tavora B, D’amico G, et al. Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc. 2012;7(1):89.

Baker L, Robinson N, Wilson D, Tabaqchali M, Leaper D. Vascular endothelial growth factor in colorectal cancer pathology, survival and treatment. Annals of Oncology. 2019 Oct;30:v12.

Li J, Huang L, Zhao H, Yan Y, Lu J. The role of Interleukins in colorectal cancer. Int J Biol Sci. 2020;16(13):2323–39.

Clark JCM, Thomas DM, Choong PFM, Dass CR. RECK—a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer and Metastasis Reviews. 2007;26(3–4):675.

Sartor L, Pezzato E, Dell’Aica I, Caniato R, Biggin S, Garbisa S. Inhibition of matrix-proteases by polyphenols: chemical insights for anti-inflammatory and anti-invasion drug design. Biochem Pharmacol. 2002;64(2):229–37.

Meissner M, Pinter A, Michailidou D, Hrgovic I, Kaprolat N, Stein M, et al. Microtubule-Targeted Drugs Inhibit VEGF Receptor-2 Expression by both Transcriptional and Post-Transcriptional Mechanisms. Journal of Investigative Dermatology. 2008;128(8):2084–91.

Gebala V, Collins R, Geudens I, Phng LK, Gerhardt H. Blood flow drives lumen formation by inverse membrane blebbing during angiogenesis in vivo. Nat Cell Biol. 2016;18(4):443.

Rodriguez SK, Guo W, Liu L, Band MA, Paulson EK, Meydani M. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer. 2006 Apr;118(7):1635–44.

Zhu BH. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis. World J Gastroenterol. 2007;13(8):1162.

Cárdenas C, Quesada AR, Medina MA. Anti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene. PLoS One. 2011/08/09. 2011;6(8):e23407–e23407.

Jana S, Chatterjee K, Ray AK, DasMahapatra P, Swarnakar S. Regulation of matrix metalloproteinase-2 Activity by COX-2-PGE2-pAKT axis promotes angiogenesis in endometriosis. PLoS One. 2016 Oct 3;11(10):e0163540.

Arnaoutova I, George J, Kleinman HK, Benton G. The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis. 2009;12(3):267–74.

Descargas

Publicado

10-09-2025

Cómo citar

[1]
2025. Anti-Angiogenic Effects of Ocimum basilicum Ethanolic Extract: In Vitro and Ex Vivo Evidence of Endothelial Inhibition. Nutrición Clínica y Dietética Hospitalaria. 45, 3 (Sep. 2025). DOI:https://doi.org/10.12873/.

Artículos similares

31-40 de 78

También puede Iniciar una búsqueda de similitud avanzada para este artículo.